OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Moderna/  US60770K1079  /

Cboe US
25/07/2024  15:46:54 Chg. -1.03 Volume Bid15:48:52 Ask15:48:57 Market Capitalization Dividend Y. P/E Ratio
117.17USD -0.87% 5,385
Turnover: 240,768.25		 116.73Bid Size: 3 117.14Ask Size: 1 45.01 bill.USD - -
GlobeNewswire 26/06 Moms For America Sues to Overturn Big Pharma Immunity
TeleTrader 26/06 US opens lower after housing data
GlobeNewswire 13/06 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire 05/06 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
TeleTrader 29/05 US opens lower, Dow Jones drops 300 points
GlobeNewswire 22/05 Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
TeleTrader 20/05 Dow slumps 195 points at closing bell after corporate news
TeleTrader 13/05 Wall Street closes mixed ahead of key inflation data
GlobeNewswire 12/05 TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
TeleTrader 02/05 US surges at close as traders weigh Fed remarks
TeleTrader 02/05 Moderna surges 9% as Q1 revenue beat expectations
GlobeNewswire 02/05 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
TeleTrader 02/05 Moderna sees $167M in Q1 revenue, beats forecasts
TeleTrader 02/05 US higher premarket after Fed's decision
GlobeNewswire 01/05 Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
TeleTrader 24/04 Moderna, OpenAI partner on mRNA medicine advancement
TeleTrader 09/04 US markets close mostly higher ahead of inflation report
GlobeNewswire 04/04 Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
TeleTrader 28/03 US closes mixed amid data
TeleTrader 26/03 Wall Street closes lower after economic data
GlobeNewswire 21/03 Immatics Announces Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 11/03 CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
GlobeNewswire 04/03 CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024